DK0421707T3 - Forbedringer i behandlingen af ufrugtbarhed - Google Patents

Forbedringer i behandlingen af ufrugtbarhed

Info

Publication number
DK0421707T3
DK0421707T3 DK90310729.0T DK90310729T DK0421707T3 DK 0421707 T3 DK0421707 T3 DK 0421707T3 DK 90310729 T DK90310729 T DK 90310729T DK 0421707 T3 DK0421707 T3 DK 0421707T3
Authority
DK
Denmark
Prior art keywords
clonidine
detecting whether
gonadotropin
blood level
patient
Prior art date
Application number
DK90310729.0T
Other languages
English (en)
Inventor
Bruno Lunenfeld
Yeheskel Menashe
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0421707T3 publication Critical patent/DK0421707T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/61—Growth hormones [GH] (Somatotropin)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Vehicle Body Suspensions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
DK90310729.0T 1989-10-02 1990-10-01 Forbedringer i behandlingen af ufrugtbarhed DK0421707T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898922137A GB8922137D0 (en) 1989-10-02 1989-10-02 Improvements in the management of infertility

Publications (1)

Publication Number Publication Date
DK0421707T3 true DK0421707T3 (da) 1995-11-06

Family

ID=10663910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90310729.0T DK0421707T3 (da) 1989-10-02 1990-10-01 Forbedringer i behandlingen af ufrugtbarhed

Country Status (13)

Country Link
US (1) US5175111A (da)
EP (1) EP0421707B1 (da)
JP (1) JP3087904B2 (da)
AT (1) ATE127927T1 (da)
AU (1) AU642909B2 (da)
CA (1) CA2026639C (da)
DE (1) DE69022344T2 (da)
DK (1) DK0421707T3 (da)
ES (1) ES2077032T3 (da)
GB (1) GB8922137D0 (da)
GR (1) GR3018087T3 (da)
IL (1) IL95865A (da)
ZA (1) ZA907865B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109813897A (zh) * 2017-11-18 2019-05-28 镇江亿特生物科技发展有限公司 盐酸可乐定快速时间分辨荧光免疫层析定量检测试纸条

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633260A (da) * 1962-02-05
NL7707691A (nl) * 1976-07-16 1978-01-18 Hoechst Ag Werkwijze voor het bereiden van nieuwe cyclopen- taanderivaten.
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
IT1191611B (it) * 1985-05-15 1988-03-23 Eugenio E Muller Formalazioni farmaceutiche per stimolare la liberazione di ormone somatotropo
US5091170A (en) * 1987-03-17 1992-02-25 Daniel Navot Fertility prediction by use of clomiphene challenge test

Also Published As

Publication number Publication date
DE69022344D1 (de) 1995-10-19
JP3087904B2 (ja) 2000-09-18
IL95865A (en) 1996-01-19
AU6366390A (en) 1991-04-11
EP0421707B1 (en) 1995-09-13
US5175111A (en) 1992-12-29
ES2077032T3 (es) 1995-11-16
JPH03218467A (ja) 1991-09-26
ATE127927T1 (de) 1995-09-15
ZA907865B (en) 1991-10-30
GR3018087T3 (en) 1996-02-29
CA2026639C (en) 2002-11-26
EP0421707A3 (en) 1992-07-15
EP0421707A2 (en) 1991-04-10
GB8922137D0 (en) 1989-11-15
CA2026639A1 (en) 1991-04-03
IL95865A0 (en) 1991-07-18
DE69022344T2 (de) 1996-03-07
AU642909B2 (en) 1993-11-04

Similar Documents

Publication Publication Date Title
DK77090A (da) Immunmodulerende azaspiraner
NO924209D0 (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
IL92269A0 (en) Pharmaceutical composition for treatment of autoimmune diseases
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
EP1019072A4 (en) ASSISTANCE PROCESS FOR DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISM SYNDROME
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
NO305932B1 (no) Farmasoeytisk akseptabel L-DOPA-etylesterbase, et farmasoeytisk preparat innneholdende base, en fremgangsmåte for fremstilling av preparatet samt L-DOPA-etylesteren
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
AU642909B2 (en) Improvements in the management of infertility
OA09027A (fr) Procédé d'inhibition. d'un virus
RU95111696A (ru) Способ обезболивания офтальмологических операций
SE8804640L (sv) Laekemedel omfattande cyklolinopeptide a
Contreras et al. Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
RU94023600A (ru) Способ лечения гемохроматоза
Bruguerolle et al. Fever‐induced changes in theophylline pharmacokinetics in rats
EP0309077A3 (en) Antidiarrhoeal therapeutic agent
SE8903117D0 (sv) Laekemedel omfattande antamanid
RU98107787A (ru) Способ обезболивания офтальмологических операций